A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients

A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients

Abstract Background Despite aggressive treatment, more than 90% of glioblastoma (GBM) patients experience recurrences. GBM response to therapy is currently assessed by imaging techniques and tissue biopsy. However, difficulties with these methods may cause misinterpretation of treatment outcomes. Cu...

Full description

Bibliographic Details
Main Authors: Juliana Muller Bark, Avinash V. Karpe, James D. Doecke, Paul Leo, Rosalind L. Jeffree, Benjamin Chua, Bryan W. Day, David J. Beale, Chamindie Punyadeera
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Cancer Medicine
Subjects:
blood
glioblastoma
lipids
metabolites
metabolomics
saliva
Online Access:https://doi.org/10.1002/cam4.5857

Similar Items

Similar Items